Mountain climbers vulnerable to subclinical lung disorder

January 24, 2002

N.B. Please note that if you are outside North America the embargo date for Lancet Press material is 0001 hours UK time Friday 25th January 2002.

Three out of four recreational climbers could be at risk of a mild form of the lung disorder called high altitude pulmonary oedema, conclude authors of a study in this week's issue of THE LANCET.

High altitude pulmonary oedema (HAPE) is characterised by increased pulmonary artery pressure which leads to accumulation of fluid in the lungs. Severe HAPE is rare, occuring in 2-5% of cases, and is thought to only affect people with a specific genetic predisposition. George Cremona from St Raffaele University, Milan, and colleagues from Italy and San Diego, USA, proposed that subclinical HAPE is far more frequent than suspected during even modest climbs of average effort.

262 climbers of Monte Rosa ( a 4559-metre mountain on the Swiss-Italian border) were assessed before ascent and about 24 hours later on the summit 1 hour after arrival. Only one climber was evacuated for HAPE, but 40 (15%) climbers had evidence of lung-function deterioration (chest rales or interstitial oedema [swelling] on radiograph after ascent). Of 37 of these climbers, 34 (92%) showed increased closing volume (the volume of air remaining in the lungs as the narrow airways begin to close after a full expiration; it is increased with oedema and is therefore used as a measure of subclinical HAPE). Of the 197 climbers without clinical evidence of oedema, 146 (74%) had an increase in closing volume -and therefore evidence of subclinical HAPE--at altitude.

George Cremona comments: "If we assume that an increased closing volume at altitude indicates increased pulmonary extravascular fluid, our data suggest that three of every four healthy, recreational climbers have mild subclinical HAPE shortly after a modest climb."

In an accompanying Commentary (p 276), Larry Sonna from the US Army Research Institute of Environmental Medicine Natick, USA, concludes: "Methods suitable for use on site to better identify individuals at risk of altitude illness, and to identify early those who become ill, are under investigation. Unfortunately, other than a history of recurrent HAPE, there is yet no widely applicable clinical method to tell precisely who will develop clinically significant pulmonary oedema at altitude. In view of the increasing popularity of recreational activities at altitudes capable of producing HAPE, better markers for susceptibility to this disorder are needed."
-end-
Contact: Dr George Cremona, Unit of Respiratory Medicine, San Raffaele University Scientific Institute, Via Olgettina 60, 20132 Milano, Italy; T) +39 02 2643 7348; F) +39 02 2643 7147; E) george.cremona@hsr.it

Dr Larry Sonna, Thermal and Mountain Medicine Division, US Army Research Institute of Environmental Medicine Natick, MA 01760, USA; E) larry.sonna@na.amedd.army.mil

Lancet

Related Risk Articles from Brightsurf:

Early life risk factors predict higher obesity and cardiometabolic risk
Early life risk factors in the first 1000 days cumulatively predict higher obesity and cardiometabolic risk in early adolescence, according to new research led by the Harvard Pilgrim Health Care Institute.

None of the most common blood pressure medications increased the risk of depression, some lowered the risk
Among the 41 most common blood pressure medications, none of them raised the risk of depression, according to an analysis from Denmark.

Lung-specific risk factors may increase hip fracture risk in individuals who smoke
Smoking has been linked to a higher risk of bone fractures.

Genetic risk scores may improve clinical identification of patients with heart attack risk
Researchers at Mass General and the Broad Institute have found that applying polygenic risk scores can identify patients at risk of a heart attack who may be missed in standard clinical evaluations.

New risk prediction model could identify those at higher risk of pancreatic cancer
A risk prediction model that combined genetic and clinical factors with circulating biomarkers identified people at significantly higher than normal risk of pancreatic cancer.

Risk of HIV-related heart disease risk varies by geography, income
People living with human immunodeficiency virus (HIV) infection are at higher risk of cardiovascular disease (CVD) compared to people without HIV.

Genetic study provides most comprehensive map of risk to date of breast cancer risk
A major international study of the genetics of breast cancer has identified more than 350 DNA 'errors' that increase an individual's risk of developing the disease.

New risk scores help physicians provide better care for high-risk pulmonary patients, study finds
Study of more than 17,000 patients finds new laboratory-based method of estimating outcomes for patients with a severe pulmonary disorder that has no cure can help physicians better provide proper care, referrals, and services for patients at the end of life.

Researchers develop model to predict suicide risk in at-risk young adults
New research from Pitt's School of Medicine shows that fluctuation and severity of depressive symptoms are much better at predicting risk of suicidal behavior in at-risk young adults.

High-risk sexually transmitted HPV virus associated with increased CVD risk
Infection with high-risk strains of the human papillomavirus (HPV), which have been linked to cancer, might increase the risk of heart and blood vessel or cardiovascular disease, especially among women with obesity or other cardiovascular risk factors.

Read More: Risk News and Risk Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.